News

Filter by
Tangka Parranthi “Sparking Hope” – Another successful ANZCHOG Annual Scientific Meeting

More than 350 delegates came together recently to attend the ANZCHOG 2024 Annual Scientific Meeting (ASM) in Adelaide (Tarntanya).

Read more
ANZCHOG welcomes four new Life Members

At this year’s Annual Scientific Meeting Gala Dinner, four pioneers of childhood cancer treatments received ANZCHOG Life Membership.

Read more
A promising advancement for New Zealand children and adolescents with cancer

In positive news for New Zealand children and adolescents with cancer, the ZERO2 study has opened at Starship Children’s Hospital, Auckland.

Read more
Management of children with DIPG: ANZCHOG Position Statement

The ANZCHOG Central Nervous System (CNS) Tumour Group has recently published a position statement for the management of children with Diffuse Intrinsic Pontine Glioma (DIPG) in Australia and New Zealand.

Read more
Bone Cancer & Sarcoma Awareness Month

July is Bone Cancer and Sarcoma Awareness Month.

Read more
Perth Children’s Hospital Opens New Clinical Trial for Children and Adolescents with Ewing Sarcoma

On the eve of Sarcoma and Bone Cancer Awareness Month, Perth Children’s Hospital has become the first international site outside of the United Kingdom to open an innovative clinical trial for children and adolescents with newly diagnosed Ewing Sarcoma.

Read more
Oncology Nursing Month – Meet Rachel Edwards

As Oncology Nursing Month comes to a close, we chatted with Rachel Edwards, a paediatric oncology research nurse, member of ANZCHOG’s Board of Directors and member of ANZCHOG’s Nursing Committee.

Read more
Celebrating International Nurses Day

To celebrate the contribution nurses make within our community, we spoke with Chris Williams about his role as Regional Nurse Educator & Service Improvement Lead with the Victorian Paediatric Integrated Cancer Service (PICS).

Read more
Interfant-21 Opens at First Australian Site

Earlier this week, Perth Children’s Hospital became the first Australian site to open Interfant-21, an international phase 3 clinical trial.

Read more

All posts loaded.

All posts loaded.

Join our newsletter

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Email info@anzchog.org   |  

Level 6, TRF Building, Hudson Institute, 27-31 Wright St, Clayton VIC 3168